CLDN3 and ovarian cancer: CTR1 gene expression was reduced in CLDN3 or CLDN4 knockdown cells, and enforced CTR1 expression restored their sensitivity to cisplatin, indicating that CTR1 plays a role in cisplatin sensitivity in ovarian cancer cells.